Regenerative Medicine

Health care products

Regenerative Medicine
Last Updated June 1, 2021
HCP
Getty Images

Regenerative medicine is a broad field that develops methods to regrow, repair, or replace damaged or diseased cells and tissues. Stem cell products, gene therapies, and other regenerative techniques have the potential to one day cure major diseases and heal traumatic injuries, but to date, only a few have been approved as safe and effective by the Food and Drug Administration (FDA). Unfortunately, this has not stopped hundreds of U.S. businesses from selling unproven—and, in many cases, harmful—treatments for a wide range of health problems.

Pew is working to ensure that FDA protects public health and safely fosters the growth of this emerging field by implementing and enforcing the agency’s regulations for regenerative medicine.

A nurse pushes a wheeled stretcher in the hallway of a hospital
A nurse pushes a wheeled stretcher in the hallway of a hospital
Issue Brief

Harms Linked to Unapproved Stem Cell Interventions

Quick View
Issue Brief

Stem cell products and other regenerative therapies have significant potential to treat traumatic injuries and serious diseases. Although some have earned approval from the Food and Drug Administration, most have not, and many of these unapproved interventions have led to life-threatening infections, chronic pain, and even death.

Pipette
Pipette
Article

FDA and Congress Move to Stop Unproven Stem Cell Interventions

Quick View
Article

The Food and Drug Administration and members of Congress have taken important steps in recent months to protect consumers from unproven and risky stem cell products offered by hundreds of clinics nationwide. However, the agency needs to take broader action to deter businesses from selling interventions whose safety and effectiveness have not been proven to regulators.

Getty Images
Getty Images
Report

FDA's Framework for Regulating Regenerative Medicine

Quick View
Report

Over the last two decades, cell therapies (which involve the transplantation of whole cells into a patient), gene therapies (which use genetic material to manipulate a patient’s cells), and other medical treatments intended to repair or replace damaged, diseased, or dysfunctional cells, tissues, and organs have generated increasing public interest.

OUR WORK

The front facade of the Supreme Court of the United States in Washington, DC.
ian-hutchinson-U8WfiRpsQ7Y-unsplash.jpg_master

Agenda for America

Resources for federal, state, and local decision-makers

Quick View

Data-driven policymaking is not just a tool for finding new solutions for emerging challenges, it makes government more effective and better able to serve the public interest.

Lightbulbs
Lightbulbs

States of Innovation

Data-driven state policy innovations across America

Quick View

Data-driven policymaking is not just a tool for finding new solutions for difficult challenges. When states serve their traditional role as laboratories of innovation, they increase the American people’s confidence that the government they choose—no matter the size—can be effective, responsive, and in the public interest.